tm
Seeing Is Believing
tm
Seeing Is Believing
Kintara Therapeutics's activity chart (see below) currently has 7 price targets and 9 ratings on display.
Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 390.67 days.
Most recent stock forecast was given by from MAXIM GROUP on 14-Jul-2023. First documented stock forecast 14-Sep-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Jul-2023
$14
$7.7 (122.22%)
3 years 1 months 29 days ago
(14-Jul-2023)
2/2 (100%)
$-148.4 (-91.38%)
593
Buy Since 29-Sep-2021
$750000
$749993.69 (11904662.00%)
$300
4 years 7 months 23 days ago
(20-Jan-2022)
1/2 (50%)
$749271.12 (102799.01%)
223
Buy Since 14-Sep-2020
$250
$243.7 (3868.25%)
4 years 11 months 11 days ago
(01-Oct-2021)
1/1 (100%)
$-1202.5 (-82.79%)
356
What is KTRA (Kintara Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KTRA (Kintara Therapeutics)?
Which analyst has the most public recommendations on KTRA (Kintara Therapeutics)?
Which analyst is the currently most bullish on KTRA (Kintara Therapeutics)?
Which analyst is the currently most reserved on KTRA (Kintara Therapeutics)?
